These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19075713)

  • 1. Development of radioligands for in vivo imaging of type 1 cannabinoid receptors (CB1) in human brain.
    Horti AG; Van Laere K
    Curr Pharm Des; 2008; 14(31):3363-83. PubMed ID: 19075713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 11C-JHU75528: a radiotracer for PET imaging of CB1 cannabinoid receptors.
    Horti AG; Fan H; Kuwabara H; Hilton J; Ravert HT; Holt DP; Alexander M; Kumar A; Rahmim A; Scheffel U; Wong DF; Dannals RF
    J Nucl Med; 2006 Oct; 47(10):1689-96. PubMed ID: 17015906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo evaluation of (11)C-SD5024, a novel PET radioligand for human brain imaging of cannabinoid CB1 receptors.
    Tsujikawa T; Zoghbi SS; Hong J; Donohue SR; Jenko KJ; Gladding RL; Halldin C; Pike VW; Innis RB; Fujita M
    Neuroimage; 2014 Jan; 84():733-41. PubMed ID: 24076222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analogs of JHU75528, a PET ligand for imaging of cerebral cannabinoid receptors (CB1): development of ligands with optimized lipophilicity and binding affinity.
    Fan H; Kotsikorou E; Hoffman AF; Ravert HT; Holt D; Hurst DP; Lupica CR; Reggio PH; Dannals RF; Horti AG
    Eur J Med Chem; 2009 Feb; 44(2):593-608. PubMed ID: 18511157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic strategies for radioligands for in vivo imaging of brain cannabinoid type-1 receptors.
    Ahamed M; Verbruggen A; Bormans G
    J Labelled Comp Radiopharm; 2013; 56(3-4):207-14. PubMed ID: 24285327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PET radioligand [11C]MePPEP binds reversibly and with high specific signal to cannabinoid CB1 receptors in nonhuman primate brain.
    Yasuno F; Brown AK; Zoghbi SS; Krushinski JH; Chernet E; Tauscher J; Schaus JM; Phebus LA; Chesterfield AK; Felder CC; Gladding RL; Hong J; Halldin C; Pike VW; Innis RB
    Neuropsychopharmacology; 2008 Jan; 33(2):259-69. PubMed ID: 17392732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candidate PET radioligands for cannabinoid CB1 receptors: [18F]AM5144 and related pyrazole compounds.
    Li Z; Gifford A; Liu Q; Thotapally R; Ding YS; Makriyannis A; Gatley SJ
    Nucl Med Biol; 2005 May; 32(4):361-6. PubMed ID: 15878505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of the cannabinoid CB₁ receptor PET ligand ortholog, [³H]MePPEP.
    Suter TM; Chesterfield AK; Bao C; Schaus JM; Krushinski JH; Statnick MA; Felder CC
    Eur J Pharmacol; 2010 Dec; 649(1-3):44-50. PubMed ID: 20851117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and labeling of high-affinity 3,4-diarylpyrazolines as candidate radioligands for in vivo imaging of cannabinoid subtype-1 (CB1) receptors.
    Donohue SR; Pike VW; Finnema SJ; Truong P; Andersson J; Gulyás B; Halldin C
    J Med Chem; 2008 Sep; 51(18):5608-16. PubMed ID: 18754613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodistribution and dosimetry in humans of two inverse agonists to image cannabinoid CB1 receptors using positron emission tomography.
    Terry GE; Hirvonen J; Liow JS; Seneca N; Tauscher JT; Schaus JM; Phebus L; Felder CC; Morse CL; Pike VW; Halldin C; Innis RB
    Eur J Nucl Med Mol Imaging; 2010 Aug; 37(8):1499-506. PubMed ID: 20333514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging and quantitation of cannabinoid CB1 receptors in human and monkey brains using (18)F-labeled inverse agonist radioligands.
    Terry GE; Hirvonen J; Liow JS; Zoghbi SS; Gladding R; Tauscher JT; Schaus JM; Phebus L; Felder CC; Morse CL; Donohue SR; Pike VW; Halldin C; Innis RB
    J Nucl Med; 2010 Jan; 51(1):112-20. PubMed ID: 20008988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of [11C]PipISB and [18F]PipISB in monkey as candidate radioligands for imaging brain cannabinoid type-1 receptors in vivo.
    Finnema SJ; Donohue SR; Zoghbi SS; Brown AK; Gulyás B; Innis RB; Halldin C; Pike VW
    Synapse; 2009 Jan; 63(1):22-30. PubMed ID: 18925657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Test-retest reproducibility of cannabinoid-receptor type 1 availability quantified with the PET ligand [¹¹C]MePPEP.
    Riaño Barros DA; McGinnity CJ; Rosso L; Heckemann RA; Howes OD; Brooks DJ; Duncan JS; Turkheimer FE; Koepp MJ; Hammers A
    Neuroimage; 2014 Aug; 97():151-62. PubMed ID: 24736184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR.
    Wong DF; Kuwabara H; Horti AG; Raymont V; Brasic J; Guevara M; Ye W; Dannals RF; Ravert HT; Nandi A; Rahmim A; Ming JE; Grachev I; Roy C; Cascella N
    Neuroimage; 2010 Oct; 52(4):1505-13. PubMed ID: 20406692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET imaging studies in rhesus monkey with the cannabinoid-1 (CB1) receptor ligand [11C]CB-119.
    Hamill TG; Lin LS; Hagmann W; Liu P; Jewell J; Sanabria S; Eng W; Ryan C; Fong TM; Connolly B; Vanko A; Hargreaves R; Goulet MT; Burns HD
    Mol Imaging Biol; 2009; 11(4):246-52. PubMed ID: 19130142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography imaging using an inverse agonist radioligand to assess cannabinoid CB1 receptors in rodents.
    Terry G; Liow JS; Chernet E; Zoghbi SS; Phebus L; Felder CC; Tauscher J; Schaus JM; Pike VW; Halldin C; Innis RB
    Neuroimage; 2008 Jul; 41(3):690-8. PubMed ID: 18456516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand.
    Terry GE; Liow JS; Zoghbi SS; Hirvonen J; Farris AG; Lerner A; Tauscher JT; Schaus JM; Phebus L; Felder CC; Morse CL; Hong JS; Pike VW; Halldin C; Innis RB
    Neuroimage; 2009 Nov; 48(2):362-70. PubMed ID: 19573609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor.
    Burns HD; Van Laere K; Sanabria-Bohórquez S; Hamill TG; Bormans G; Eng WS; Gibson R; Ryan C; Connolly B; Patel S; Krause S; Vanko A; Van Hecken A; Dupont P; De Lepeleire I; Rothenberg P; Stoch SA; Cote J; Hagmann WK; Jewell JP; Lin LS; Liu P; Goulet MT; Gottesdiener K; Wagner JA; de Hoon J; Mortelmans L; Fong TM; Hargreaves RJ
    Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9800-5. PubMed ID: 17535893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [18F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users.
    Ceccarini J; Kuepper R; Kemels D; van Os J; Henquet C; Van Laere K
    Addict Biol; 2015 Mar; 20(2):357-67. PubMed ID: 24373053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assay of CB1 Receptor Binding.
    Catani VM; Gasperi V
    Methods Mol Biol; 2016; 1412():41-55. PubMed ID: 27245890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.